Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| RDNT | RADNET INC | $4.55B | 77,612,125 | 71.05% | 28.95% | Net Selling | Net Selling | ||
| RRR | RED ROCK RESORTS INC | $5.56B | 105,026,832 | 16.85% | 83.15% | Net Buying | Net Selling | ||
| TEAM | ATLASSIAN CORP | $22.53B | 253,767,862 | 59.05% | 0.92% | Net Selling | Net Selling | ||
| MDB | MONGODB INC | $21.32B | 80,369,527 | 89.60% | 10.40% | Net Selling | Net Selling | ||
| NEO | NEOGENOMICS INC | $1.16B | 130,211,780 | 72.92% | 27.08% | Net Buying | |||
| MSTR | STRATEGY INC | $62.35B | 333,752,708 | 50.42% | 0.12% | Net Buying | Net Selling | ||
| OI | O-I GLASS INC | $1.39B | 153,299,563 | 94.78% | 5.22% | Net Selling | Net Selling | ||
| DFTX | DEFINIUM THERAPEUTICS INC | $2.33B | 99,698,129 | 60.15% | 39.85% | Net Selling | Net Selling | ||
| HRI | HERC HOLDINGS INC | $4.54B | 33,393,051 | 80.70% | 19.30% | Net Selling | Net Buying | ||
| SDGR | SCHRODINGER INC | $969.87M | 74,720,724 | 79.90% | 20.10% | Net Buying | Net Buying | ||
| FA | FIRST ADVANTAGE CORP | $2.23B | 174,319,117 | 66.67% | 33.33% | Net Selling | Net Buying | ||
| AEYE | AUDIOEYE INC | $95.72M | 12,495,980 | 32.48% | 67.52% | Net Buying | Net Buying | ||
| PAYP | PAYPAY CORP | N/A | 668,625,454 | 0.00% | 0.00% | Net Buying | Net Buying | ||
| AVBP | ARRIVENT BIOPHARMA INC | $1.31B | 44,201,622 | 80.12% | 19.88% | Net Selling | |||
| FRMI | FERMI INC | $3.50B | 629,839,790 | 7.19% | 34.47% | Net Selling | Net Selling | ||
| NUVL | NUVALENT INC | $8.20B | 78,617,001 | 77.47% | 22.53% | Net Selling | Net Selling | ||
| BTGO | BITGO HOLDINGS INC | $1.37B | 115,466,965 | 0.00% | 12.93% | Net Selling | Net Selling | ||
| NOC | NORTHROP GRUMMAN CORP | $79.48B | 142,033,476 | 82.87% | 4.53% | Net Selling | Net Selling | ||
| STVN | STEVANATO GROUP SPA | $5.75B | 302,842,536 | 16.77% | 83.23% | ||||
| ALIT | ALIGHT INC | $502.86M | 537,241,981 | 72.58% | 27.42% | Net Buying | Net Buying | ||
| CRC | CALIFORNIA RESOURCES CORP | $5.46B | 88,794,901 | 91.56% | 8.44% | Net Selling | Net Selling | ||
| OTLY | OATLY GROUP AB | $337.54M | 624,500,001 | 0.46% | 0.10% | ||||
| CWH | CAMPING WORLD HOLDINGS INC | $812.57M | 102,986,748 | 61.15% | 17.83% | Net Selling | Net Selling | ||
| MIDD | MIDDLEBY CORP | $6.72B | 47,181,017 | 90.11% | 9.89% | Net Buying | Net Selling | ||
| KIDS | ORTHOPEDIATRICS CORP | $439.73M | 25,684,994 | 42.33% | 57.67% | Net Selling | Net Selling | ||
| NRIX | NURIX THERAPEUTICS INC | $1.75B | 103,405,813 | 93.04% | 6.96% | Net Selling | Net Selling | ||
| CNXC | CONCENTRIX CORP | $1.45B | 61,004,826 | 73.00% | 27.00% | Net Selling | Net Selling | ||
| TARA | PROTARA THERAPEUTICS INC | $306.12M | 54,084,378 | 55.44% | 44.56% | Net Selling | Net Selling | ||
| RVLV | REVOLVE GROUP INC | $1.44B | 71,555,543 | 64.45% | 19.14% | Net Selling | Net Selling | ||
| CPNG | COUPANG INC | $32.11B | 1,795,064,201 | 77.15% | 22.85% | Net Selling | Net Buying | ||
| THC | TENET HEALTHCARE CORP | $16.75B | 86,137,000 | 31.79% | 68.21% | Net Selling | Net Selling | ||
| REAL | THEREALREAL INC | $1.55B | 118,982,805 | 71.41% | 28.59% | Net Selling | Net Selling | ||
| TELA | TELA BIO INC | $44.29M | 44,740,371 | 47.85% | 52.15% | Net Buying | Net Selling | ||
| LAKE | LAKELAND INDUSTRIES INC | $103.26M | 10,723,205 | 62.27% | 18.98% | Net Selling | Net Selling | ||
| DEC | DIVERSIFIED ENERGY CO | $1.17B | 76,070,756 | 69.69% | 12.38% | Net Selling | Net Selling | ||
| AKBA | AKEBIA THERAPEUTICS INC | $396.46M | 267,879,239 | 44.14% | 8.15% | Net Selling | Net Buying | ||
| NHI | NATIONAL HEALTH INVESTORS INC | $3.58B | 48,471,079 | 70.98% | 9.42% | Net Buying | Net Buying | ||
| SGHT | SIGHT SCIENCES INC | $233.96M | 54,409,942 | 35.92% | 57.04% | Net Buying | Net Selling | ||
| EQT | EQT CORP | $35.88B | 625,478,000 | 88.37% | 11.63% | Net Selling | Net Selling | ||
| ATRC | ATRICURE INC | $1.40B | 49,809,901 | 75.20% | 24.80% | Net Selling | Net Selling | ||
| MDLN | MEDLINE INC | $55.19B | 1,313,688,164 | 30.90% | 69.10% | Net Selling | Net Selling | ||
| LMRI | LUMEXA IMAGING HOLDINGS INC | $988.01M | 96,109,927 | 29.42% | 0.43% | ||||
| OM | OUTSET MEDICAL INC | $82.59M | 18,311,626 | 61.22% | 38.78% | Net Selling | Net Selling | ||
| ESTC | ELASTIC NV | $5.08B | 103,501,008 | 58.23% | 41.77% | Net Selling | Net Selling | ||
| CACI | CACI INTERNATIONAL INC | $11.03B | 22,091,305 | 87.38% | 12.62% | Net Selling | Net Selling | ||
| ACET | ADICET BIO INC | $82.05M | 9,596,407 | 29.24% | 70.76% | Net Buying | Net Buying | ||
| RBRK | RUBRIK INC | $11.69B | 202,276,140 | 57.11% | 5.19% | Net Selling | Net Selling | ||
| FLUT | FLUTTER ENTERTAINMENT PLC | $17.24B | 173,972,199 | 82.70% | 17.30% | Net Selling | Net Selling | ||
| BRZE | BRAZE INC | $2.49B | 113,448,702 | 44.06% | 55.94% | Net Selling | Net Selling | ||
| JMIA | JUMIA TECHNOLOGIES AG | $923.94M | 247,705,230 | 12.68% | 5.24% | ||||
| DIS | WALT DISNEY CO | $187.65B | 1,736,511,424 | 78.76% | 0.96% | Net Selling | Net Buying | ||
| AMLX | AMYLYX PHARMACEUTICALS INC | $1.78B | 110,536,944 | 66.79% | 33.21% | Net Selling | Net Selling | ||
| APYX | APYX MEDICAL CORP | $122.14M | 41,829,226 | 45.49% | 20.04% | Net Buying | Net Buying | ||
| ORKA | ORUKA THERAPEUTICS INC | $3.46B | 49,542,691 | 25.56% | 74.44% | Net Buying | Net Selling | ||
| CGTX | COGNITION THERAPEUTICS INC | $109.91M | 89,353,773 | 24.06% | 30.40% | Net Selling | Net Buying | ||
| PERI | PERION NETWORK LTD | $415.62M | 39,024,964 | 57.66% | 1.66% | Net Selling | Net Selling | ||
| ACRS | ACLARIS THERAPEUTICS INC | $517.89M | 108,345,239 | 51.55% | 48.45% | Net Selling | Net Selling | ||
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | $2.01B | 373,322,192 | 0.01% | 22.93% | ||||
| ARVN | ARVINAS INC | $656.24M | 63,960,997 | 70.83% | 29.17% | Net Selling | Net Selling | ||
| DC | DAKOTA GOLD CORP | $757.04M | 133,517,177 | 37.43% | 20.61% | Net Buying | Net Buying | ||
| VKTX | VIKING THERAPEUTICS INC | $3.75B | 116,105,643 | 61.96% | 8.85% | Net Selling | Net Buying | ||
| ERAS | ERASCA INC | $3.39B | 310,799,547 | 70.55% | 27.68% | Net Buying | Net Buying | ||
| CP | CANADIAN PACIFIC KANSAS CITY LTD | $76.33B | 887,736,404 | 68.94% | 0.01% | ||||
| CRVO | CERVOMED INC | $35.46M | 9,258,719 | 3.05% | 96.95% | Net Buying | |||
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $161.55M | 57,288,750 | 65.18% | 34.82% | Net Buying | Net Buying | ||
| SRRK | SCHOLAR ROCK HOLDING CORP | $5.41B | 114,883,096 | 60.18% | 39.82% | Net Buying | Net Selling | ||
| TCOM | TRIPCOM GROUP LTD | $35.37B | 649,583,574 | 24.26% | 1.28% | ||||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $531.96M | 51,051,487 | 80.75% | 19.25% | Net Buying | Net Selling | ||
| TLX | TELIX PHARMACEUTICALS LTD | $3.76B | 338,777,049 | 0.33% | 7.54% | ||||
| DMRA | DAMORA THERAPEUTICS INC | $1.49B | 60,303,212 | 1.84% | 27.36% | Net Selling | |||
| KYMR | KYMERA THERAPEUTICS INC | $7.10B | 82,257,588 | 77.04% | 22.96% | Net Buying | Net Selling | ||
| IRON | DISC MEDICINE INC | $2.62B | 38,199,089 | 60.49% | 39.51% | Net Selling | Net Selling | ||
| MSLE | SATELLOS BIOSCIENCE INC | $119.03M | 15,458,923 | 0.00% | 0.00% | ||||
| NGNE | NEUROGENE INC | $503.52M | 15,574,293 | 47.95% | 52.05% | Net Selling | Net Selling | ||
| SRTA | STRATA CRITICAL MEDICAL INC | $461.19M | 86,526,570 | 60.10% | 29.96% | Net Selling | Net Selling | ||
| AGMB | AGOMAB THERAPEUTICS NV | $596.54M | 48,736,779 | 0.00% | 0.09% | ||||
| WALD | WALDENCAST PLC | $155.17M | 128,237,613 | 16.55% | 13.18% | ||||
| CABA | CABALETTA BIO INC | $415.23M | 111,322,671 | 68.49% | 3.91% | Net Buying | |||
| AGBK | AGI INC | $1.26B | 183,566,434 | 0.00% | 1.99% | ||||
| APGE | APOGEE THERAPEUTICS INC | $5.87B | 69,485,247 | 94.89% | 5.11% | Net Selling | Net Selling | ||
| HELP | CYBIN INC | $276.41M | 49,894,131 | 60.30% | 0.00% | ||||
| CRBP | CORBUS PHARMACEUTICALS HOLDINGS INC | $193.68M | 17,736,464 | 47.30% | 52.70% | Net Selling | Net Selling | ||
| EXOD | EXODUS MOVEMENT INC | $243.86M | 29,811,917 | 10.34% | 15.48% | Net Selling | Net Selling | ||
| EQ | EQUILLIUM INC | $137.20M | 63,226,556 | 55.81% | 22.62% | Net Selling | Net Selling | ||
| PHAR | PHARMING GROUP NV | $1.15B | 701,680,440 | 0.02% | 0.00% | ||||
| PCOR | PROCORE TECHNOLOGIES INC | $7.95B | 150,100,482 | 35.21% | 64.79% | Net Selling | Net Selling | ||
| VOR | VOR BIOPHARMA INC | $776.68M | 48,847,504 | 52.26% | 26.07% | Net Selling | Net Selling | ||
| RACE | FERRARI NV | $59.35B | 176,514,000 | 34.04% | 0.00% | ||||
| CRVS | CORVUS PHARMACEUTICALS INC | $1.30B | 83,992,407 | 55.58% | 38.94% | Net Buying | |||
| BNTX | BIONTECH SE | $22.86B | 239,970,804 | 19.96% | 17.34% | Net Selling | Net Selling | ||
| DSGX | DESCARTES SYSTEMS GROUP INC | $6.12B | 86,022,028 | 75.83% | 0.00% | ||||
| ELTX | ELICIO THERAPEUTICS INC | $192.24M | 18,396,074 | 11.31% | 62.00% | Net Buying | |||
| BMEA | BIOMEA FUSION INC | $115.68M | 72,299,440 | 32.13% | 25.19% | Net Buying | |||
| ASMB | ASSEMBLY BIOSCIENCES INC | $497.45M | 15,862,705 | 52.43% | 47.57% | Net Selling | Net Selling | ||
| IMUX | IMMUNIC INC | $143.77M | 13,046,482 | 75.87% | 24.13% | Net Buying | |||
| ARGX | ARGENX SE | $49.97B | 61,883,306 | 48.47% | 0.00% | ||||
| GMAB | GENMAB A | $17.92B | 64,238,408 | 100.00% | 0.00% | ||||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $714.67M | 243,085,387 | 31.30% | 0.71% | ||||
| PDS | PRECISION DRILLING CORP | $1.18B | 12,932,399 | 54.97% | 0.00% | ||||
| BHVN | BIOHAVEN LTD | $1.51B | 150,560,990 | 78.70% | 15.72% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.